NORTH HOLLYWOOD, Calif. & CHICAGO--(BUSINESS WIRE)--The International Myeloma Foundation (IMF)—supporting research and providing education, advocacy and support for myeloma patients, families, researchers and physicians—today said encouraging new findings were presented at the American Society of Clinical Oncology (ASCO) meeting in Chicago, showing significant improvements in treating myeloma. Several presentations show the drug regimens referred to as the “novel therapies” extend survival and improve the response to treatments at levels not previously seen.
